Clinical Trial Update: Remote Psychological Intervention for COVID-19 Survivors With AKI and Caregivers (REPICOV-AKI) [NA]

View source ↗

Summary

The REPICOV-AKI trial evaluating a remote psychological intervention for COVID-19 survivors with acute kidney injury and their caregivers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Depressive Disorders
• Kidney Injury

Snippet

Sponsor: Jesus Rivero, MD | Conditions: COVID-19, Anxiety | NA | Status: COMPLETED